Quantcast
 
Learn to trade in these market conditions - Click here Just Released!


OCLS

OCLS: Development Agreement w/Bayer Taiwan for Microcyn(R) Technology - 12/02 - 08:52 AM ET

Oculus Innovative Sciences Announces Agreement with Bayer Taiwan Co. Ltd. for Development of Microcyn(R) Technology Use in Taiwanese Animal Market - 12/02 - 08:08 AM ET

Oculus Innovative Sciences receives notification from NASDAQ regarding stockholders' equity - 11/27 - 08:08 AM ET

Oculus Innovative Sciences Receives NASDAQ Notification - 11/26 - 05:00 PM ET

OCLS: To Present At Rodman & Renshaw Investment Conference @ 11:10 ET [delayed] - 11/11 - 09:54 AM ET

BRIEF-Oculus Innovative Sciences Q2 results - 11/06 - 04:22 PM ET

Oculus Innovative Sciences to Present at the Rodman & Renshaw 10th Annual Healthcare Conference on November 11 - 11/04 - 08:08 AM ET

OCLS: Q2 Earnings Call @ 09:30 ET Today [delayed] - 10/30 - 09:50 AM ET

Oculus introduces Microcyn wound care for US podiatry market - 10/23 - 08:40 AM ET

Oculus Innovative Sciences Provides Clinical and Business Update - 10/09 - 08:08 AM ET

OCLS: To Present At Merriman Curhan Ford Investor Conference @ 18:30 ET [delayed] - 09/15 - 04:53 PM ET

Oculus launches topical wound drug in China - 09/12 - 12:06 PM ET

OCULUS AND SINOPHARM INTRODUCE DERMACYN TO HOSPITALS IN CHINA - 09/12 - 02:55 AM ET

Oculus Innovative Sciences and Sinopharm Announce Introduction of Dermacyn(TM) to Hospitals in China - 09/11 - 08:08 AM ET

[video] Hojabr Alimi, CEO of Oculus Innovative Sciences, Inc. Discusses Reduction of Planned Expenses on WallSt.net's 3-Minute Press Show - 09/11 - 07:00 AM ET

Oculus Innovative Sciences to Present at the Merriman Curhan Ford 5th Annual Investor Summit on September 15 - 09/10 - 08:08 AM ET

Oculus Innovative to reduce expenses; says operating chief to depart - 09/09 - 08:24 AM ET

Oculus Innovative Sciences Reduces Planned Expenses While Accelerating Global Commercialization - 09/09 - 08:08 AM ET

OCLS: Results of End-of-Phase II Meeting with FDA - 09/04 - 09:26 AM ET

Oculus Innovative Sciences Holds Successful End-of-Phase II Meeting with FDA for Microcyn(R) Technology - 09/04 - 08:08 AM ET

Page 1 of 7     1  2   3   4   5   >   >>|     Previous  |  Next

<< Back to Stock Index

 

Most Popular News
PREMIER SPONSORED LINKS
TRADE CENTER
 
The TradingMarkets Directory
RELATED SITES
Nothing but forex
Please call 1-213-955-5858 ext. 1

About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback


All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.

© 2008 The Connors Group, Inc.